Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 11 (UBE2V1P11) is a non-functional copy of the *UBE2V1* gene, classified as a pseudogene. It does not produce a functional protein and lacks a biological role in cellular processes or disease. The parent gene, *UBE2V1*, encodes ubiquitin-conjugating enzyme E2 variant 1, involved in non-canonical polyubiquitination and protein aggregation, but these functions are not associated with the pseudogene. UBE2V1P11 itself is not a therapeutic target and has no direct clinical or pharmacological relevance[5]. There is no evidence from current databases or literature that UBE2V1P11 has an active gene product, disease association, or role as a biomarker or therapeutic target. If structured information about a druggable target is required, the functional *UBE2V1* gene, rather than this pseudogene, should be considered[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2V1 pseudogene 11 (UBE2V1P11).